People Background Check
Find People:

Adel Moussa21 Beacon St APT 8C, Boston, MA 02108

Get Report

Adel Moussa Phones & Addresses

21 Beacon St APT 8C, Boston, MA 02108

9 Chandler Rd, Burlington, MA 01803 (781) 365-1056

34 Newbridge Ave, Burlington, MA 01803 (617) 270-6662

Work

Position: Precision Production Occupations

Education

Degree: High school graduate or higher

Emails

a***[email protected]

Mentions for Adel Moussa

Adel Moussa resumes & CV records

Resumes

Adel Moussa Photo 26

Tour Guide - Egittologo

Location:
Washington, DC
Industry:
Leisure, Travel, & Tourism
Work:
Expedia, Inc. Apr 2014 - Sep 2014
Assistenza Clienti Professionale Eden Viaggi Dec 2012 - Apr 2014
Assistenza Clienti Professionale Phone & Go Spa 2009 - 2012
Assistenza Clienti Professionale Inviaggi S.r.l. 2005 - 2009
Assistenza Clienti Professionale Alba Tour Jun 2001 - May 2005
Assistenza Clienti Jun 2001 - May 2005
Tour Guide - Egittologo
Education:
Sinai High Institute For Toursim and Hotels 2012 - 2014
University of Calabria 2014
Ain Shams University 1994 - 1998
Skills:
Assistenza Clienti, Turismo, Management, Hotel, Vendite, Gestione Eventi, Pubbliche Relazioni, Strategia Di Marketing, Viaggi Di Piacere
Languages:
Italian
English
German
Adel Moussa Photo 27

Executive Vice President, Chemistry

Location:
21 Beacon St, Boston, MA 02108
Industry:
Pharmaceuticals
Work:
Atea Pharmaceuticals
Executive Vice President, Chemistry Idenix Pharmaceuticals Mar 2002 - Aug 2014
Vice President Cmc at Idenix Pharmaceuticals
Education:
Northeastern University Jan 1, 1985 - Dec 31, 1990
Skills:
Biotechnology, Gmp, Pharmaceutical Industry, Clinical Development, Validation, Business Development, Hplc, Product Development, Drug Development, Lifesciences, Cro, Oncology, Regulatory Affairs, Technology Transfer, Strategy, Drug Discovery, Sop, Ind, Protein Chemistry, Biopharmaceuticals, Fda, Medicinal Chemistry, Analytical Chemistry, Clinical Trials, Regulatory Submissions, Glp, Pharmaceutics, Organic Chemistry, Chemistry, Commercialization, Formulation, Good Laboratory Practice, High Performance Liquid Chromatography, Life Sciences, Standard Operating Procedure
Adel Moussa Photo 28

Vp, Cmc

Location:
Burlington, MA
Industry:
Pharmaceuticals
Work:
Idenix Pharmaceuticals Mar 2002 - Aug 2014
Vp, Cmc
Skills:
Cro, Gmp, Biotechnology, Regulatory Affairs, Validation, Drug Discovery, Lifesciences, Organic Chemistry, Oncology, Drug Development, Clinical Development, Medicinal Chemistry, Cmc, Formulation, Pharmaceutical Industry, Technology Transfer, Glp, R&D, Fda, Sop, Ind, Biopharmaceuticals

Publications & IP owners

Us Patents

Substituted Diphenyl Indanone, Indane And Indole Compounds And Analogues Thereof Useful For The Treatment Of Prevention Of Diseases Characterized By Abnormal Cell Proliferation

US Patent:
6043272, Mar 28, 2000
Filed:
Nov 20, 1997
Appl. No.:
8/975391
Inventors:
Carlo Brugnara - Newton Highlands MA
Jose Halperin - Brookline MA
Rudolf Fluckiger - Brookline MA
Emile Bellot - Beverly MA
Richard John Lombardy - Littleton MA
John J. Clifford - Arlington MA
Reem M. Haidar - Woburn MA
Eugene W. Kelleher - Somerville MA
Adel M. Moussa - Burlington MA
Yesh P. Sachdeva - Concord MA
Minghua Sun - Libertyville IL
Heather N. Taft - Littleton MA
Assignee:
Ion Pharmaceuticals, Inc. - New York NY
President and Fellows of Harvard College - Cambridge MA
Children's Medical Center Corporation - Boston MA
International Classification:
A61K 31335
C07C25500
C07C 6976
C07C 6952
US Classification:
514467
Abstract:
The present invention provides substituted 3,3-diphenyl indanone, indane and indole compounds, as well as analogues thereof, which are specific, potent and safe inhibitors of mammalian cell proliferation. The compounds can be used to inhibit mammalian cell proliferation in situ as a therapeutic approach towards the treatment or prevention of diseases characterized by abnormal cell proliferation, such as cancer.

Synthesis Of Nitroalcohol Diastereomers

US Patent:
6462221, Oct 8, 2002
Filed:
May 19, 2000
Appl. No.:
09/574620
Inventors:
Richard L. Gabriel - Swampscott MA
Adel M. Moussa - Burlington MA
Sharon Fitzhenry - Marblehead MA
Changhua Liu - Carlisle MA
David A. Swanson - Lexington MA
Brittany La - Lawrence MA
Salah Zahr - Acton MA
Yesh P. Sachdeva - Concord MA
Jurjus Jurayj - Acton MA
Assignee:
Pharm-Eco Laboratories, Inc. - Devens MA
International Classification:
C07C20502
US Classification:
560 22, 564355, 562402, 562437
Abstract:
The present invention relates to a method of preparing a 1-nitro-3-substituted-3-amino-2-propanol diastereomer represented by Structural Formula I: In Structural Formula I, R is an amine protecting group, and R is an amino acid side-chain, a protected amino acid side-chain, a substituted or unsubstituted aliphatic group, a substituted or unsubstituted aromatic group, a substituted or unsubstituted heteroaromatic group, a substituted or unsubstituted aralkyl or a substituted or unsubstituted heteroaralkyl group. The method involves contacting a 1-nitro-3-substituted-3-amino-2-propanone with a reducing agent to form a mixture of 1-nitro-3-substituted-3-amino-2-propanol diastereomers. The 1-nitro-3-substituted-3-amino-2-propanol diastereomers are then separated by simulated moving bed chromatography to obtain one or more 1-nitro-3-substituted-3-amino-2-propanol diastereomer.

Substitute 11-Phenyl-Dibenzazepine Compounds Useful For The Treatment Or Prevention Of Diseases Characterized By Abnormal Cell Proliferation

US Patent:
6534497, Mar 18, 2003
Filed:
Sep 22, 2000
Appl. No.:
09/554848
Inventors:
Carlo Brugnara - Newton Highlands MA
Jose Halperin - Brookline MA
Rudolf Fluckiger - Brookline MA
Richard John Lombardy - Littleton MA
John J. Clifford - Bedford MA
Reem M. Haidar - Woburn MA
Eugene W. Kelleher - Somerville MA
Adel M. Moussa - Burlington MA
Yesh P. Sachdeva - Concord MA
Minghua Sun - Cambridge MA
Heather N. Taft - Littleton MA
Michael H. Zeldin - Cambridge MA
Assignee:
Nuchem Pharmaceuticals, Inc. - Markham
Childrens Medical Center Corporation - Boston MA
Presidents and Fellows of Harvard College - Cambridge MA
International Classification:
C07D22320
US Classification:
514217, 540587
Abstract:
The present invention provides substituted 11-phenyl-dibenzazepine compounds that are specific, potent and safe inhibitors of mammalian cell proliferation. The compounds can be used to inhibit mammalian cell proliferation in situ as a therapeutic approach towards the treatment or prevention of diseases characterized by abnormal cell proliferation, such as cancer.

Methods Of Separating Ftc Isomers And Derivatives Thereof

US Patent:
6541631, Apr 1, 2003
Filed:
May 26, 2000
Appl. No.:
09/579796
Inventors:
Salah Zahr - Acton MA
David A. Swanson - Burlington MA
Adel M. Moussa - Burlington MA
Luning Han - Allston MA
Assignee:
Pharma-Eco Laboratories, Inc. - Devens MA
International Classification:
C07D41104
US Classification:
544317
Abstract:
The present invention relates to a method of preparing enantiomers and diastereomers of a 2â,3â-dideoxy-5-fluoro-3âthiocytadine (FTC) or a derivative thereof as represented by the following structural formula: In Structural Formula I, R is H, a substituted or unsubstituted organic acid radical, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted heteroaryl group, a substituted or unsubstituted aralkyl group, a substituted or unsubstituted heteroaralkyl group, a substituted or unsubstituted cycloalkyl group, a substituted or unsubstituted heterocycloalkyl group, a substituted or unsubstituted cycloalkylalkyl, a substituted or unsubstituted heterocycloalkylalkyl, a sugar or a protecting group.

Methods Of Separating Ftc Isomers And Derivatives Thereof

US Patent:
6752929, Jun 22, 2004
Filed:
Jul 12, 2002
Appl. No.:
09/979414
Inventors:
Salah Zahr - Acton MA
David A. Swanson - Burlington MA
Adel M. Moussa - Burlington MA
Luning Han - Allston MA
Assignee:
Johnson Matthey Pharmaceutical Materials, Inc. - Devens MA
International Classification:
B01D 1508
US Classification:
210659, 2101982, 544317
Abstract:
The present invention relates to a method of preparing enantiomers and diastereomers of a 2â,3â-dideoxy-5-fluoro-3âthiocytadine (FTC) or a derivative thereof as represented by the structural formula (I), wherein R is H, a substituted or unsubstituted organic acid radical, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted heteroaryl group, a substituted or unsubstituted aralkyl group, a substituted or unsubstituted heteroarakyl group, a substituted or unsubstituted cycloalkyl group, a substituted or unsubstituted heterocycloalkyl group, a substituted or unsubstitued cycloalkylalkyl group, a substituted or unsubstituted heterocycloalkylalkyl group, a sugar or a protecting group.

Substituted Diphenyl Indanone, Indane And Indole Compounds And Analogues Thereof Useful For The Treatment Of Prevention Of Diseases Characterized By Abnormal Cell Proliferation

US Patent:
6800658, Oct 5, 2004
Filed:
Jan 10, 2002
Appl. No.:
10/043640
Inventors:
Carlo Brugnara - Newton Highlands MA
Jose Halperin - Brookline MA
Rudolf Fluckiger - Brookline MA
Richard John Lombardy - Littleton MA
John J. Clifford - Arlington MA
Reem M. Haidar - Woburn MA
Eugene W. Kelleher - Somerville MA
Adel M. Moussa - Burlington MA
Yesh P. Sachdeva - Concord MA
Minghua Sun - Cambridge MA
Heather N. Taft - Littleton MA
Assignee:
Childrens Medical Center Corporation - Cambridge MA
President Fellows of Harvard College - Cambridge MA
Nuchem Pharmaceuticals, Inc.
International Classification:
C07C 2200
US Classification:
514467, 514475, 514544, 514546, 514640, 514617, 514717, 549430, 549453, 549550, 558388, 560 56, 560 57, 560221, 564180, 564265
Abstract:
The present invention provides substituted 3,3-diphenyl indanone, indane and indole compounds, as well as analogues thereof, which are specific, potent and safe inhibitors of mammalian cell proliferation. The compounds can be used to inhibit mammalian cell proliferation in situ as a therapeutic approach towards the treatment or prevention of diseases characterized by abnormal cell proliferation, such as cancer.

Substituted 11-Phenyl-Dibenzazepine Compounds Useful For The Treatment Or Prevention Of Diseases Characterized By Abnormal Cell Proliferation

US Patent:
6992079, Jan 31, 2006
Filed:
Dec 7, 2001
Appl. No.:
10/013308
Inventors:
Carlo Brugnara - Newton Highlands MA, US
Jose Halperin - Brookline MA, US
Rudolf Fluckiger - Brookline MA, US
Richard John Lombardy - Littleton MA, US
John J. Clifford - Arlington MA, US
Reem M. Haidar - Woburn MA, US
Eugene W. Kelleher - Medford MA, US
Adel M. Moussa - Burlington MA, US
Yesh P. Sachdeva - Concord MA, US
Minghua Sun - Libertyville IL, US
Heather N. Taft - Littleton MA, US
Michael H. Zeldin - Cambridge MA, US
Assignee:
President Fellows of Harvard College - Cambridge MA
Children's Medical Center Corporation - Boston MA
NuChem Pharmaceuticals Inc. - Toronto
International Classification:
A61K 31/55
C07D 233/18
US Classification:
514217, 540587
Abstract:
The present invention provides substituted 11-phenyl-dibenzazepine compounds which are specific, potent and safe inhibitors of mammalian cell proliferation. The compounds can be used to inhibit mammalian cell proliferation in situ as a therapeutic approach towards the treatment or prevention of diseases characterized by abnormal cell proliferation, such as cancer.

Substituted Diphenyl Indanone, Indane And Indole Compounds And Analogues Thereof Useful For The Treatment Or Prevention Of Diseases Characterized By Abnormal Cell Proliferation

US Patent:
7342038, Mar 11, 2008
Filed:
Jun 1, 2004
Appl. No.:
10/858975
Inventors:
Carlo Brugnara - Newton Highlands MA, US
Jose Halperin - Brookline MA, US
Rudolf Fluckiger - Brookline MA, US
Richard John Lombardy - Littleton MA, US
John J. Clifford - Bedford MA, US
Reem M. Haidar - Woburn MA, US
Eugene W. Kelleher - Somerville MA, US
Adel M. Moussa - Burlington MA, US
Yesh P. Sachdeva - Concord MA, US
Minghua Sun - Cambridge MA, US
Heather N. Taft - Littleton MA, US
Assignee:
President and Fellow of Harvard College - Cambridge MA
Children's Medical Center Corporation - Boston MA
NuChem Pharmaceuticals Inc. - Toronto
International Classification:
C07D 209/10
C07D 209/12
A61K 31/404
US Classification:
514415, 548469, 548483, 548490
Abstract:
The present invention provides substituted 3,3-diphenyl indole compounds, as well as analogues thereof, which are specific potent and safe inhibitors of mammalian cell proliferation. The compounds can be used to inhibit mammalian cell proliferation in situ as a therapeutic approach towards the treatment or prevention of diseases characterized by abnormal cell proliferation, such as cancer.

Public records

Vehicle Records

Adel Moussa

Address:
34 Newbridge Ave, Burlington, MA 01803
Phone:
(781) 365-1056
VIN:
2HKYF185X7H522252
Make:
HONDA
Model:
PILOT
Year:
2007

Possible Relatives

Davina J Moussa  Diagne M Moussa  Elias Moussa  Elie B Moussa  Abdoulaye Moussa  Farid G Moussa  Hanna M Moussa  Adel Khoury  Adel S Mustafa  Adel Padilla 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.